CJC-1295 without DAC × ascensionpeptides.com — Lab Test, June 2026
COA KVR-2026-1EE33C matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
8STMMESTest results
About this test
Label 10 mg · Lab measured 11.43 mg
114% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.9 mg using the measured mass, against 2.5 mg on the label — 14% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-1EE33C |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 23 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of CJC-1295 without DAC from ascensionpeptides.com, performed by Kovera Labs on June 26, 2026. Reported purity: 99.227%. Net content: 11.43 mg against 10 mg labeled (114% of label). Tested content exceeds the labeled amount by 14%. Endotoxins: PASS (≤0.5 EU/mL). Heavy metals: Arsenic <0.15, Cadmium <0.05, Lead <0.5, Mercury <0.3. Batch 60-05260628. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of CJC-1295 without DAC from ascensionpeptides.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 13-05260628 | 14 Jun 2026 | Kovera Labs | 99.621% | 109% | ✓ Lab-verified |
| 13-01260229 | 10 Apr 2026 | MZ Biolabs | 99.27% | 104% | Unverified |
| 60-03260429 | 20 Mar 2026 | MZ Biolabs | 99.66% | 105% | Unverified |
| 13-03250428 | 12 Aug 2025 | MZ Biolabs | 98.67% | — | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion